Teglarinad Chloride

N/A

Report date: 2022/11/25 17:01:20
NME

Base Information

Drug NameTeglarinad Chloride
Drug Alias Name氯替拉利那cloruro de teglarinad氯特拉利那teglarinadi chloridumEB-1627 +[6] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionNicotinamide phosphoribosyltransferase inhibitors
TargetsNicotinamide phosphoribosyltransferase
Therapy Area/IndicationsSolid tumoursMelanoma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesLeo Pharma Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesGemin X Biotechnologies IncGemin X Pharmaceuticals Inc
Active IndicationsN/A
Inactive IndicationsSolid tumoursMelanoma

Other Information

ATC CodeN/A
Related LinksKEGG